- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.07. | Summit counters PD-1/VEGF skeptics; Celldex drug fails skin disease study | ||
| 22.07. | Crystalys nets $130M more to push gout drug through late-stage tests | ||
| 21.07. | Agios scraps sickle cell drug | ||
| 21.07. | Novo sues Lilly, alleging 'misleading' advertising of obesity drugs | ||
| 21.07. | Dimension restocks with $800M to capitalize on AI's 'rapid ascent' | ||
| 21.07. | Novartis climbs on upbeat drug sales as key readouts loom | ||
| 20.07. | Tempus to acquire cancer test maker Personalis for $1.5B | ||
| 20.07. | Pain drugmaker Latigo outlines plans to go public | ||
| 20.07. | [Podcast] From Protocol to Patient: Inside Clinical Supply with Almac Clinical Services | ||
| 20.07. | Bristol Myers to build 'powerful' AI factory; Samsung Biologics bids for peptide maker | ||
| 17.07. | Jasper Therapeutics gets a lifeline in merger with immune drugmaker Kira Pharmaceuticals | ||
| 17.07. | GSK shelves cough drug acquired in $2B deal | ||
| 17.07. | Arbutus, Sanofi escalate mRNA patent fights; InnoCare's TYK2 contender advances | ||
| 17.07. | How well are AI-discovered drugs faring in the clinic? | ||
| 16.07. | Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics | ||
| 16.07. | Veradermics keeps 'momentum going' as baldness drug helps women with hair loss | ||
| 16.07. | Merck wins first approval of a PCSK9 cholesterol pill | ||
| 15.07. | Celcuity gains FDA approval for closely-watched breast cancer drug | ||
| 15.07. | Braveheart Bio, Attovia join next wave of biotech IPOs | ||
| 15.07. | Merck ADC, in China study, shows potential to replace chemo in lung cancer | ||
| 15.07. | J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals | ||
| 14.07. | CVS Caremark reaches settlement with FTC over insulin suit | ||
| 14.07. | Judge orders Apple Tree partner to forfeit oversight of venture fund | ||
| 14.07. | Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill | ||
| 14.07. | Draig bags another $65M to speed testing of brain drugs |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.